SCHEMBL6979360

SCHEMBL6979360

N#Cc1ccc(CCC(=O)N2CCCc3cc(N4CCCC4=O)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RORC P51449 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
BLM P54132 1/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
PARP1 P09874 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985487 0.99 TP53 (0.41) TP53ALDH1A1MEN1KMT2AHPGD
SCHEMBL6979722 0.84 TP53 (0.48) TP53ALDH1A1MEN1KMT2AHPGD
Hydrochloric Acid SCHEMBL6986625 0.83 ITGB3 (0.44) ALDH1A1POLBNPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL7407544 0.83 ITGB3 (0.43) ALDH1A1HPGDPOLBNPC1RAB9A
SCHEMBL7959087 0.82 TP53 (0.48) TP53ALDH1A1MEN1KMT2AHPGD
SCHEMBL6979364 0.81 ALDH1A1 (0.41) TP53ALDH1A1MEN1KMT2AHPGD
SCHEMBL6979462 0.81 MAPT (0.58) TP53ALDH1A1MEN1KMT2AHPGD
SCHEMBL6985490 0.80 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AHPGDUSP2
SCHEMBL6986432 0.80 TP53 (0.48) TP53ALDH1A1MEN1KMT2AHPGD
SCHEMBL6981640 0.79 NR3C1 (0.47) TP53ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed